Results 41 to 50 of about 1,337 (171)

Fluralaner [PDF]

open access: yes, 2019
Fluralaner är en ny ektoparasiticid som tillhör substansgruppen isoxazoliner och introducerades på marknaden 2014 av MSD Animal Health. För närvarande finns det bara två veterinärmedicinska läkemedel på marknaden som innehåller fluralaner, vilka är ...
Nilsson, Sanna
core   +1 more source

Effect of fluralaner on the biology, survival, and reproductive fitness of the neotropical malaria vector Anopheles aquasalis

open access: yesMalaria Journal, 2023
Background Reducing mosquito abundance or interfering with its ability to support the parasite cycle can help to interrupt malaria in areas of significant risk of malaria transmission.
João Arthur Alcântara   +13 more
doaj   +1 more source

Effects of Feed Intake and Water Hardness on Fluralaner Pharmacokinetics in Layer Chickens

open access: yesJournal of Veterinary Science, 2022
Fluralaner is a novel drug belonging to the isoxazoline class that acts on external parasites of domestic animals. It is used systemically via drinking water, especially against red poultry mite in layer chickens. Fluralaner is frequently used in layers infected with D. gallinae. However, no study to date has investigated the effects of feed intake and
Ataman Bilge Sari   +6 more
openaire   +2 more sources

Field effectiveness and safety of fluralaner plus moxidectin (Bravecto® Plus) against ticks and fleas: a European randomized, blinded, multicenter field study in naturally-infested client-owned cats

open access: yesParasites & Vectors, 2018
Background A spot-on formulation containing fluralaner (280 mg/ml) plus moxidectin (14 mg/ml) (Bravecto® Plus) has been developed to provide broad spectrum parasite protection for cats. The effectiveness and safety of this product against ticks and fleas
Nadja Rohdich   +6 more
doaj   +1 more source

Treatment of dogs with fluralaner reduced pyrethroid-resistant Triatoma infestans abundance, Trypanosoma cruzi infection and human-triatomine contact in the Argentine Chaco

open access: yesParasites & Vectors, 2022
Background Triatomine elimination efforts and the interruption of domestic transmission of Trypanosoma cruzi are hampered by pyrethroid resistance. Fluralaner, a long-lasting ectoparasiticide administered to dogs, substantially reduced site infestation ...
Ricardo Esteban Gürtler   +6 more
doaj   +1 more source

N318L Blocks the Interaction of Fluralaner but Not Broflanilide or Fipronil with the Insect GABA Receptor In Vivo [PDF]

open access: yes
Fluralaner is a novel insecticide targeting the ionotropic GABA receptor (GABAR) subunit, RDL. A recent study revealed that N316L, a substitution of asparagine (N) with leucine (L), in the second transmembrane (M2)-spanning region reduced the antagonist ...
Zhang Yichi   +7 more
core   +5 more sources

Safety of fluralaner, a novel systemic antiparasitic drug, in MDR1(-/-) Collies after oral administration

open access: yesParasites & Vectors, 2014
Background Fluralaner is a novel systemic ectoparasiticide for dogs providing long-acting flea- and tick-control after a single oral dose. This study investigated the safety of oral administration of fluralaner at 3 times the highest expected clinical ...
Feli M Walther   +4 more
doaj   +1 more source

Flea and tick treatment satisfaction, preference and adherence of dog owners in the United States, United Kingdom and Australia who treated their dog with fluralaner [PDF]

open access: yesOpen Veterinary Journal, 2020
Background: An extended duration flea and tick medication of the isoxazoline class (fluralaner) was introduced in 2014 in the United States and other countries.
Robert Lavan   +4 more
doaj   +1 more source

Efficacy of fluralaner plus moxidectin (Bravecto® Plus spot-on solution for cats) against Otodectes cynotis infestations in cats

open access: yesParasites & Vectors, 2018
Background The efficacy of the fixed combination of fluralaner plus moxidectin for the treatment of Otodectes cynotis infestations was evaluated in cats after topical application. Methods Sixteen cats experimentally infested with O.
Janina Taenzler   +3 more
doaj   +1 more source

The benefits of multidisciplinary collaboration in the successful management of two complex feline cases

open access: yesAustralian Veterinary Journal, EarlyView.
Despite a frequent misconception that behavioural concerns are diagnoses of exclusion, medical conditions and behavioural disorders are frequently inter‐related. In human medicine, the ‘multidisciplinary team’ approach (MDTA) is considered the most efficacious way of managing patients with complex and chronic health conditions.
BE Bollaert, JM Ley, HE Zulch
wiley   +1 more source

Home - About - Disclaimer - Privacy